Literature DB >> 11699555

Silent mixed corticotroph and somatotroph macroadenomas presenting with pituitary apoplexy.

T Abe1, M Taniyama, B Xu, H Ozawa, N Kawamura, M Shimazu, K Sasaki, H Izumiyama, M Kushima, J Kuwazawa, T Sano, K Matsumoto.   

Abstract

We discuss three unique cases of pituitary macroadenoma presenting with pituitary hemorrhage but without typical endocrine symptomatology. Immunohistochemical analysis indicated positive reactivity for adrenocorticotropic hormone (ACTH) and growth hormone (GH), and in situ hybridization indicated the expression of proopiomelanocortin (POMC) and GH mRNA. We designated these cases silent mixed corticotroph and somatotroph adenoma. Patient 1 was a 30-year-old man, patient 2 was a 29-year-old woman, and patient 3 was a 59-year-old woman. All patients presented with a headache of sudden onset and visual disturbance. The patients did not exhibit typical Cushing's or acromegalic features. Serum ACTH level was remarkably elevated in patient 1, and slightly elevated in patients 2 and 3. In all patients, serum GH levels were within normal range and magnetic resonance imaging revealed an intra- and suprasellar mass with pituitary hemorrhage. Transnasal pituitary surgery in the three patients disclosed a pituitary adenoma producing ACTH and GH. In patient 2, the residual adenoma reappeared along with an intratumoral hemorrhage, and was resected by secondary transnasal surgery. Silent mixed corticotroph and somatotroph adenomas are characterized by the following: no endocrine symptoms; presentation dominated by mass effect symptoms; macroadenoma presenting with acute pituitary hemorrhage; and production of both ACTH and GH.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11699555     DOI: 10.1007/s004010100396

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  7 in total

1.  Co-localization of honeycomb golgi and ACTH granules in a giant ACTH-producing pituitary adenoma.

Authors:  Kyongsong Kim; Shozo Yamada; Masaaki Usui; Toshiaki Sano
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 2.  The pituitary mass: diagnosis and management.

Authors:  Susan Sam; Mark E Molitch
Journal:  Rev Endocr Metab Disord       Date:  2005-01       Impact factor: 6.514

Review 3.  Silent somatotroph pituitary adenomas: an update.

Authors:  Fabienne Langlois; Randall Woltjer; Justin S Cetas; Maria Fleseriu
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

4.  Symptomatic cystic degeneration of a clinically silent corticotroph tumor of the pituitary gland.

Authors:  Michael T Walsh; William T Couldwell
Journal:  Skull Base       Date:  2010-09

5.  Silent Corticotroph and Somatotroph Double Pituitary Adenoma: A Case Report and Review of Literature.

Authors:  Isabella L Pecorari; Lakshmi Priyanka Mahali; Abigail Funari; Roger Fecher; Nisha Suda; Vijay Agarwal
Journal:  J Neurol Surg Rep       Date:  2022-05-27

Review 6.  Modification of hormonal secretion in clinically silent pituitary adenomas.

Authors:  Tania Daems; Johan Verhelst; Alex Michotte; Pascale Abrams; Dirk De Ridder; Roger Abs
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

7.  Clinically silent somatotroph adenomas are common.

Authors:  Alisha N Wade; Jennifer Baccon; M Sean Grady; Kevin D Judy; Donald M O'Rourke; Peter J Snyder
Journal:  Eur J Endocrinol       Date:  2011-04-14       Impact factor: 6.664

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.